Monday, November 20, 2017

© Reuters.  Piper Jaffray downgrades Imperva© Reuters. Piper Jaffray downgrades Imperva

  • Piper Jaffray downgrades Imperva (NASDAQ:IMPV) from Overweight to Neutral and cuts the price target from $58 to $42.
  • Analyst Andrew Nowinski cites headwinds including deteriorating demand, loss of the CEO and CFO in Q3, potential downside for FY18 revenue estimates, and the current valuation.
  • Imperva shares are down 5.85%.
  • Previously: Imperva announces interim CFO (Oct. 9)
  • Now read: Synchronoss Technologies: Strong Comeback Seems To Be Imminent

Original article

sponsoredArticle = ‘div-gpt-ad-1466339494851-0’;

Banner Content

FOLLOW US

GOOGLE PLUS

PINTEREST

FLICKR

INSTAGRAM

Archivies